NCT02316431CompletedNot Applicable
Diagnostic Comparison and Workflow Evaluation of Whole Body PET-magnetic Resonance and PET-CT With and Without Contrast Media in Patients With Oncologic Diseases
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- University of Zurich
- Enrollment
- 142
- Locations
- 1
- Primary Endpoint
- Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT
Study Overview
Brief Summary
Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Male and female patients from 18-90 years
- •Written informed consent
- •Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media
Exclusion Criteria
- •Pregnant or breast feeding women
- •Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
- •Inclusion in another clinical trial 30 days prior to inclusion
- •Age < 30years
- •Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
- •Known allergies to contrast CT or MRI contrast media
- •Patients with an glomerular filtration rate of < 60ml/min/1.73m2
Outcomes
Primary Outcomes
Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT
Time Frame: 12 month
Secondary Outcomes
- Number of minutes needed per PET/magnetic resonance protocol compared to PET/CT(12 month)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast CancerChemotherapy EffectBreast CancerNCT04882371Cem Ilgin Erol88
Withdrawn
Not Applicable
PET/MRI in Endometrial CancerCytoreductive SurgeryGrade 3 Endometrial Endometrioid AdenocarcinomaHigh Grade Serous CarcinomaEndometrial Undifferentiated CarcinomaEndometrial Mixed Cell AdenocarcinomaNCT05390021Massachusetts General Hospital
Recruiting
Not Applicable
Measurement of Head and Neck Tumor Hypoxia With PET-MRIHead and Neck CancerNCT05246475Turku University Hospital30
Completed
Not Applicable
PET/MRI and PET/CT in Diagnosing Younger Patients With CancerChildhood CancerNCT02287636Case Comprehensive Cancer Center13
Active, not recruiting
Not Applicable
PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian CancerMalignant Ovarian NeoplasmOvarian CarcinomaNCT03965481M.D. Anderson Cancer Center21